Cargando…
Neuroimaging as a Selection Tool and Endpoint in Clinical and Pre-clinical Trials
Standard imaging in acute stroke enables the exclusion of non-stroke structural CNS lesions and cerebral haemorrhage from clinical and pre-clinical ischaemic stroke trials. In this review, the potential benefit of imaging (e.g., angiography and penumbral imaging) as a translational tool for trial re...
Autores principales: | Muir, Keith W., Macrae, I. Mhairi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014902/ https://www.ncbi.nlm.nih.gov/pubmed/27543177 http://dx.doi.org/10.1007/s12975-016-0487-1 |
Ejemplares similares
-
Phase III Preclinical Trials in Translational Stroke Research: Community Response on Framework and Guidelines
por: Boltze, Johannes, et al.
Publicado: (2016) -
Sex differences in imaging and clinical characteristics of patients from the WAKE‐UP trial
por: Wouters, Anke, et al.
Publicado: (2022) -
Clinical presentation and neural correlates of stroke‐associated spatial delusions
por: Alves, Pedro N., et al.
Publicado: (2022) -
Predicting Atrial Fibrillation after Ischemic Stroke: Clinical, Genetics, and Electrocardiogram Modelling
por: Poh, Mervyn Qi Wei, et al.
Publicado: (2022) -
Outcomes of Mild Stroke and High-Risk Transient Ischemic Attack in Current Clinical Practice
por: Wesanonthawech, Apiluk, et al.
Publicado: (2022)